Partnering with
MOGRIFY
Mogrify is looking to partner with disruptive innovators in the fields of regenerative medicine, ex vivo cell therapy and in vivo reprogramming therapy to develop treatments for indications of high unmet clinical. We are particularly interested in speaking with those with interest in hematological, immunological, ophthalmological as well as other disease areas where these modalities may be of interest. Mogrify is commercializing its technology via a combination of internal therapy development, co-development partnerships, and out-licensing of novel cell conversions applicable to non-core markets.
Our
PIPELINE
| AREA | Sample Acquisition | Bioinformatics | In vitro PoC | In vivo PoC | IND | Clinical | Marketing |
|---|---|---|---|---|---|---|---|
| Ophthalmology | mogrify | mogrify | mogrify | partner | partner | ||
| Immunology (& hematology) | mogrify | mogrify | mogrify | mogrify | partner | partner | |
| Collaborations (Pancreatic, Lung, Immune & Others) | mogrify | mogrify | mogrify | partner | partner | partner | partner |
| mogrify | Mogrify Progress | partner | Expect to Partner |
Upcoming
Events & Conferences
BIO-Europe Digital comes at a time when global connections are more important than ever. With the same powerful one-to-one partnering and valuable content, BIO-Europe Digital continues to help you drive your life science partnering forward. Join the BIO-Europe Digital to schedule virtual partnering meetings during the week of October 26–29.
This meeting will provide a forum for biologists, methods developers and computational modelers interested in understanding biology at single-cell resolution.
Focusing on the specific needs of the Biotech and Emerging Pharma segments and their partners, this one day conference provides a unique forum to discuss the major challenges impacting the sector.
We are proud to be sponsoring the 3rd Annual London Stem Cell Network Symposium at The Francis Crick Institute.
The 62nd American Society of Hematology (ASH) Annual Meeting and Exposition is the premier event in malignant and non-malignant hematology.
We are proud to be sponsoring the Cambridge International Stem Cell Symposium in September 2021.